Related content

Prospective association of dopamine-related polymorphisms with smoking cessation in general care

By Breitling Lutz P   Twardella Dorothee   Hoffmann Michael M   Witt Stephanie H   Treutlein Jens   Brenner Hermann  

Pharmacogenomics, Vol. 11, Iss. 4, 2010-04 ,pp. : 527-536

Future Medicine

Access to resources Recommend Favorite

Dopamine D4 receptor gene polymorphisms: relation to ethnicity, no association with schizophrenia and response to clozapine in Israeli subjects

By Kohn Y.   Ebstein R.P.   Heresco-Levy U.   Shapira B.   Nemanov L.   Gritsenko I.   Avnon M.   Lerer B.  

European Neuropsychopharmacology, Vol. 7, Iss. 1, 1997-02 ,pp. : 39-43

Elsevier

Access to resources Recommend Favorite

Serotonin and dopamine receptor gene polymorphisms and the risk of extrapyramidal side effects in perphenazine-treated schizophrenic patients

By Gunes Arzu   Scordo Maria   Jaanson Peeter   Dahl Marja-Liisa  

Psychopharmacology, Vol. 190, Iss. 4, 2007-03 ,pp. : 479-484

Springer Publishing Company

Access to resources Recommend Favorite

Sexual dysfunction in male schizophrenia: influence of antipsychotic drugs, prolactin and polymorphisms of the dopamine D2 receptor genes

By Zhang Xiang Rong   Zhang Zhi Jun   Zhu Rong Xin   Yuan Yong Gui   Jenkins Trisha A   Reynolds Gavin P  

Pharmacogenomics, Vol. 12, Iss. 8, 2011-08 ,pp. : 1127-1136

Future Medicine

Access to resources Recommend Favorite

Effects of dopamine D₁- or D₂-like receptor antagonists on the hypermotive and discriminative stimulus effects of (+)-MDMA

By Bubar Marcy   Pack Kami   Frankel Paul   Cunningham Kathryn  

Psychopharmacology, Vol. 173, Iss. 3-4, 2004-05 ,pp. : 326-336

Springer Publishing Company

Access to resources Recommend Favorite